Avilar Therapeutics

Avilar develops extracellular protein degraders that link disease-causing proteins to ASGPR ligands, clearing them via the liver for degradation.
Domain
Healthcare
Status
Current Private Investment
Stage of Initial Investment
NewCo
Initial Investment Year
2020
Avilar Portco Hover Image Wide